India Glycols Limited (NSE:INDIAGLYCO) responded on 19 August 2026 to an NSE surveillance query dated 18 August 2026, confirming there is no undisclosed price-sensitive information behind a recent spike in the company's traded volumes, attributing the movement to market-driven activity.
Key Highlights
- NSE's surveillance department, via reference No. NSE/CM/Surveillance/17369 dated 18 August 2026, sought an explanation from India Glycols for the unusual increase in trading volumes.
- India Glycols confirmed there is no undisclosed announcement, information, or corporate event that would require disclosure under the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- The company stated it is unaware of any specific reason for the volume increase and characterised the movement as market-driven rather than linked to any internal development.
- India Glycols reaffirmed its commitment to timely disclosure of all material information to stock exchanges in compliance with applicable SEBI Listing Regulations.
About the Company
India Glycols Limited (NSE:INDIAGLYCO, BSE:500201), headquartered in Noida, Uttar Pradesh, manufactures green glycols, ethylene oxide derivatives, potable alcohol, and industrial gases. The company operates manufacturing facilities at Kashipur, Uttarakhand, and counts bulk chemicals, pharma-grade solvents, and natural gum products among its core offerings across domestic and export markets.
Announcement in Detail
India Glycols filed letter IGL/SE/2026-27/41 on 19 August 2026 in direct response to an NSE surveillance communication, reference No. NSE/CM/Surveillance/17369, sent on 18 August 2026. The NSE surveillance team addressed the query to Shri Amit Shinde, Chief Manager, Surveillance, and sought the company's clarification on a noticeable increase in trading volumes in the INDIAGLYCO scrip.
In its written response, the company's Head (Legal) and Company Secretary, Ankur Jain, stated explicitly that apart from information already disclosed to the exchanges from time to time, there is no undisclosed information, announcement, or event requiring disclosure under the SEBI Listing Regulations. The company added it has no knowledge of any specific internal trigger for the volume surge, characterising the movement as purely market-driven in nature. The same filing was simultaneously submitted to BSE Limited under scrip code 500201.
Impact on Investors
Investors will note that the company's response follows a standard regulatory process under which listed entities are required to explain unusual price or volume movements to exchanges. The filing shows that no material corporate development, such as a merger, acquisition, fund-raising, or earnings revision, has been withheld from the public domain.
Shareholders will observe that the company's denial of any undisclosed event means the volume movement cannot be attributed to an imminent corporate action as of the filing date. The disclosed terms indicate the company remains committed to its ongoing SEBI disclosure obligations, which provides a degree of transparency on the governance process, though the underlying cause of the trading activity remains unresolved from a market standpoint.
Sector / Market Context
India's specialty chemicals sector has seen increased investor interest over the past several years, driven by import substitution policies and growth in downstream industries such as pharmaceuticals, agrochemicals, and personal care. The NSE surveillance framework routinely monitors unusual volume or price movements across listed companies and issues such clarification queries as a standard investor-protection measure, consistent with SEBI's broader market integrity mandate. India Glycols operates in the bio-based green chemicals space, a segment that has attracted attention as manufacturers seek alternatives to petroleum-derived inputs.